Chinese clinical guidelines on diagnosis and treatment of lung cancer bone metastasis (version 2024)
10.7507/1007-4848.202402042
- VernacularTitle:中国肺癌骨转移临床诊疗指南（2024版）
- Author:
Xiuyi ZHI
1
;
Jie WANG
2
;
Lunxu LIU
3
;
Jun ZHAO
4
Author Information
1. Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, P. R. China
2. Department of Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, P. R. China
3. Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu, 610041, P. R. China
4. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department 1 of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, 100142, P. R. China
- Collective Name:Lung Cancer Medical Education Committee of Chinese Medicine Education Association, Youth Expert Committee on Lung Cancer of Beijing Medical Award Foundation, Lung Cancer Professional Committee of China Geriatric Health Association
- Publication Type:Journal Article
- Keywords:
Lung cancer;
bone metastasis;
bone-modifying therapy;
clinical guideline;
recommendations
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2024;31(05):643-653
- CountryChina
- Language:Chinese
-
Abstract:
Lung cancer is the highest morbidity of malignant tumor in China, and bone metastasis is one of the common sites. With the development of imaging and nuclear medicine technology, the level of early diagnosis of bone metastasis has been improved. There are also many evidence-based evidences and advances in systemic therapy (chemotherapy, targeted therapy, immunotherapy) and bone modification drugs for treatment of bone metastases from lung cancer. The comprehensive treatment model under the guidance of multiple disciplines (including medical oncology, surgery, radiotherapy, interventional medicine, nuclear medicine, psychological rehabilitation, etc.) has been widely implemented in clinical practice. Therefore, Lung Cancer Medical Education Committee of China Medicine Education Association, Youth Specialists Committee of Lung Cancer, Beijing Medical Award Foundation and Lung Cancer Specialty Committee of Chinese Elderly Health Care Association have written the "Chinese Clinical Guidelines on Diagnosis and Treatment of Lung Cancer Bone Metastasis (Version 2024)", based on the "Expert Consensus on Diagnosis and Treatment of Lung Cancer Bone Metastasis (Version 2019)". The aim is to enhance the comprehensive treatment level of lung cancer bone metastasis in China.
